A randomized controlled trial compared coronary artery plaque progression after androgen deprivation therapy using relugolix vs leuprolide in men with prostate cancer.
So the REVELUTION trial was designed to test our hypothesis that ADT-associated cardiovascular risk is at least partly mediated by accelerated coronary atherosclerosis. And we hypothesized that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback